Tag: psoriasis
INVEX Health develops oral fluid-based HIV self-test
Recently acquired the global licensing rights for a patented product addressing Psoriasis
Eli Lilly forays into dermatological space, launches psoriasis drug Copellor in...
Post approval from the Drugs Controller General of India, the drug will be available for treatment of adults with moderate-to-severe plaque psoriasis
Janssen launches icare4u program for disorders caused by excessive inflammation
Research shows that people living with inflammatory disorders are at increased risk of depression and anxiety, with those most affected also experiencing worse disease activity
Sun Pharma initiates Phase 2 clinical trial of Psoriasis drug
SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis, are also expected to be initiated soon......................
Sun Pharma announces 5-year sustained efficacy & safety results for its...
ILUMYA is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials in moderate-to-severe plaque psoriasis.......................
Lupin & Mylan launch arthritis biosimilar, Nepexto in Germany
Nepexto is Lupin’s biosimilar etanercept approved for all indications of the reference product Enbrel. It is available as an injectable in an easy-to-use pre-filled pen and a pre-filled syringe...................
Sun Pharma seals US$ 145 million deal with SPARC over potential...
The two companies have announced a worldwide licensing agreement on the development and commercialization of SCD-044 which is being evaluated as a potential oral treatment for atopic dermatitis, psoriasis and other auto-immune disorders.............
Glenmark aims to transform the treatment for Psoriasis in India
Launches Apremilast, a revolutionary advanced oral treatment that addresses various limitations of the current therapies available in India................
Dr Reddy’s Labs out-licenses its psoriasis drug to Encore Dermatology
DFD-06, a topical high potency steroid is being commercialized in the United States market by Promius Pharma, LLC, the fully owned subsidiary of Dr Reddy's Lab..........
Sun Pharma achieves breaking results for its Psoriasis drug
The company has achieved primary end point in both Phase-3 studies in patients with moderate-to-severe plaque Psoriasis...